Tanke Biosciences Corp SEC filings TNBI

Tanke Biosciences Corp has 127 filings in SEC EDGAR's recent list, going back to Dec 16, 2008. Its latest annual report, Form 10-K, was filed on Apr 15, 2013 for the period ended Dec 31, 2012. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2013, covering the quarter ended Sep 30, 2013. The most recent current report (Form 8-K) was filed on Dec 26, 2013 (auditor change). The company's fiscal year ends on December 31.

Tanke Biosciences Corp SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
10-Q Quarterly report Aug 14, 2013 Jun 30, 2013
10-Q Quarterly report May 20, 2013 Mar 31, 2013
10-Q Quarterly report Nov 14, 2012 Sep 30, 2012
10-Q/A Amended quarterly report Aug 27, 2012 Jun 30, 2012
10-Q Quarterly report Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 17, 2012 Mar 31, 2012
10-Q Quarterly report Nov 21, 2011 Sep 30, 2011
10-Q/A Amended quarterly report Nov 3, 2011 Jun 30, 2011
10-Q/A Amended quarterly report Oct 21, 2011 Jun 30, 2011
10-Q/A Amended quarterly report Oct 21, 2011 Mar 31, 2011
10-Q Quarterly report Aug 22, 2011 Jun 30, 2011
10-Q/A Amended quarterly report Aug 15, 2011 Mar 31, 2011
10-Q Quarterly report May 20, 2011 Mar 31, 2011
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
10-Q Quarterly report Aug 16, 2010 Jun 30, 2010
10-Q Quarterly report May 14, 2010 Mar 31, 2010
10-Q Quarterly report Nov 23, 2009 Sep 30, 2009
10-Q Quarterly report Aug 4, 2009 Jun 30, 2009
10-Q Quarterly report May 6, 2009 Mar 31, 2008

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Grain Mill Products (SIC 2040)
Listed as
TNBI (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Pearl River New City Guangzhou, China
SEC CIK
1452011
Former names
GREYHOUND COMMISSARY, INC. (until Feb 3, 2011)

Other Grain Mill Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.